| Date | Title | Description | Source |
| 18.01.2024 | Eurocine Vaccines contracts Artemis Bioservices as CRO | Eurocine Vaccines contracts Artemis Bioservices as CRO
Thu, Jan 18, 2024 12:38 CET Report this cont... | news.cisio... |
| 28.11.2023 | Correction - Eurocine Vaccines discloses interim report for ... | Correction - Eurocine Vaccines discloses interim report for July – September 2023
Tue, Nov 28, 2023... | news.cisio... |
| 28.11.2023 | Eurocine Vaccines discloses interim report for Juli – Septem... | Eurocine Vaccines discloses interim report for Juli – September 2023
Tue, Nov 28, 2023 09:04 CET Re... | news.cisio... |
| 24.05.2023 | Eurocine Vaccines discloses interim report for July 2022 – M... | Eurocine Vaccines discloses interim report for July 2022 – March 2023
Wed, May 24, 2023 08:00 CET R... | news.cisio... |
| 04.05.2023 | Eurocine Vaccines receives grant from Merck Group | Eurocine Vaccines receives grant from Merck Group
Thu, May 04, 2023 08:00 CET Report this content
... | news.cisio... |
| 28.02.2023 | Eurocine Vaccines discloses half-year report for July – Dece... | Eurocine Vaccines discloses half-year report for July – December 2022
Tue, Feb 28, 2023 08:15 CET R... | news.cisio... |
| 20.02.2023 | Eurocine Vaccines’ Director of Preclinical Development invit... | Eurocine Vaccines’ Director of Preclinical Development invited to lecture at UCL School of Pharmacy
... | news.cisio... |
| 17.01.2023 | Eurocine Vaccines decides to develop mRNA-based vaccine cand... | Eurocine Vaccines decides to develop mRNA-based vaccine candidate against chlamydia
Tue, Jan 17, 20... | news.cisio... |
| 20.12.2022 | Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 ... | Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate
Tue, Dec 20, 2022 12:03 CET R... | news.cisio... |
| 30.08.2022 | Eurocine Vaccines´ newly added HSV-2 vaccine candidate gains... | Eurocine Vaccines´ newly added HSV-2 vaccine candidate gains patent protection in South Korea
Tue, ... | news.cisio... |
| 25.08.2022 | Eurocine Vaccines discloses year-end report for the fiscal y... | Eurocine Vaccines discloses year-end report for the fiscal year 2021/2022
Thu, Aug 25, 2022 08:00 C... | news.cisio... |
| 28.07.2022 | Disclosure notice in Eurocine Vaccines | Disclosure notice in Eurocine Vaccines
Thu, Jul 28, 2022 12:50 CET Report this content
Eurocine Va... | news.cisio... |
| 04.07.2022 | Eurocine Vaccines outlines a strategic development plan for ... | Eurocine Vaccines outlines a strategic development plan for its newly added therapeutic HSV-2 vaccin... | news.cisio... |
| 14.06.2022 | Eurocine Vaccines expands its portfolio with a therapeutic H... | Eurocine Vaccines expands its portfolio with a therapeutic HSV-2 vaccine candidate
Tue, Jun 14, 202... | news.cisio... |
| 20.05.2022 | Eurocine Vaccines publishes interim report for July 2021 – M... | Eurocine Vaccines publishes interim report for July 2021 – March 2022
Fri, May 20, 2022 08:15 CET R... | news.cisio... |
| 08.03.2022 | Eurocine Vaccines publishes CEO interview | Eurocine Vaccines publishes CEO interview
Tue, Mar 08, 2022 07:46 CET Report this content
CEO Hans... | news.cisio... |
| 16.02.2022 | Eurocine Vaccines publishes half-year report for July - Dece... | Eurocine Vaccines publishes half-year report for July - December 2021
Wed, Feb 16, 2022 08:00 CET R... | news.cisio... |
| 15.02.2022 | Eurocine Vaccines enters into agreement with Flerie Invest t... | Eurocine Vaccines enters into agreement with Flerie Invest to secure exercise of warrants of series ... | news.cisio... |
| 21.12.2021 | Eurocine Vaccines resolves on scientific advice with the Swe... | Eurocine Vaccines resolves on scientific advice with the Swedish Medical Products Agency ahead of cl... | news.cisio... |
| 01.12.2021 | Eurocine Vaccines´ Chlamydia vaccine candidate elicits both ... | Eurocine Vaccines´ Chlamydia vaccine candidate elicits both antibody and T cell responses Wed, Dec 0... | news.cisio... |
| 17.11.2021 | Eurocine Vaccines discloses interim report for July - Septem... | Eurocine Vaccines AB hereby discloses the interim report for July - September 2021. Below is a summa... | marketscre... |
| 17.11.2021 | Correction: Eurocine Vaccines discloses interim report for J... | Correction: Eurocine Vaccines discloses interim report for July – September 2021 Wed, Nov 17, 2021 1... | news.cisio... |
| 17.11.2021 | Eurocine Vaccines discloses interim report for July – Septem... | Eurocine Vaccines discloses interim report for July – September 2021 Wed, Nov 17, 2021 09:59 CET
Eu... | news.cisio... |
| 15.10.2021 | Disclosure notice in Eurocine Vaccines | Disclosure notice in Eurocine Vaccines Fri, Oct 15, 2021 19:23 CET
Eurocine Vaccines hereby announc... | news.cisio... |
| 31.08.2021 | Eurocine Vaccines discloses year-end report for the fiscal y... | Eurocine Vaccines discloses year-end report for the fiscal year 2020/2021 Tue, Aug 31, 2021 08:15 CE... | news.cisio... |
| 25.08.2021 | Eurocine Vaccines extends its product portfolio with a diagn... | Eurocine Vaccines extends its product portfolio with a diagnostic test of chlamydia through a widene... | news.cisio... |
| 25.08.2021 | Eurocine Vaccines : extends its product portfolio with a dia... | Eurocine Vaccines AB has decided to evaluate a diagnostic test of chlamydia antibodies in blood as a... | marketscre... |
| 10.06.2021 | Eurocine Vaccines prepares to evaluate two more vaccine cand... | Eurocine Vaccines prepares to evaluate two more vaccine candidates Thu, Jun 10, 2021 10:45 CET
As p... | news.cisio... |
| 27.05.2021 | Eurocine Vaccines publishes interim report for July 2020 - M... | Eurocine Vaccines publishes interim report for July 2020 - March 2021 Thu, May 27, 2021 08:00 CET
E... | news.cisio... |
| 19.05.2021 | Eurocine Vaccines´ Adjuvant Technology Endocine™ is evaluate... | Eurocine Vaccines´ Adjuvant Technology Endocine™ is evaluated with a vaccine candidate against COVID... | news.cisio... |
